/WBA

WBA Stock - Walgreens Boots Alliance, Inc.

Q: What is the analyst price target for WBA?

Analyst price target information is not currently available for WBA.

Q: What is WBA's market cap?

Market capitalization information is not currently available for WBA.

Healthcare|Medical - Pharmaceuticals|NASDAQ

$11.98+0.50%

+$0.06 (+0.50%) • Aug 28

GoAI Score

Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.

HOLD

Medium Confidence

Momentum

Momentum Score

Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.

Sentiment

Sentiment Score

Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).

Risk Score

Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.

Price Target

Average analyst price target from the last quarter. Shows expected upside/downside from current price.

+-24.9%upside

Target: $9.00

AI Analysis PreviewPremium

Real-time AI-powered market analysis

Precise entry/exit price targets

Risk assessment & position sizing

Unlock GoAI Insights for WBA

Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.

Buy/Sell Signals

94% win rate on Alpha signals

Deep Analysis

Institutional-grade thesis

Real-Time Alerts

SMS & push notifications

Risk Scoring

Multi-factor analysis

Free 14-day trial • No credit card required

Financial Statements

Revenue & Profitability Trend

FY2020

FY2021

FY2022

FY2023

FY2024

← Swipe to see more →

Revenue

Net Income (Profit)

Net Loss

Key Metrics

Market CapN/A

P/E RatioN/A

Beta0.77

52W High$13.25

52W Low$8.08

Avg VolumeN/A

Income Statement (Fiscal Year)

Metric	FY2024	FY2023	FY2022	FY2021	FY2020
Revenue	$147.66B	$139.08B	$132.70B	$132.51B	$121.98B
Gross Profit	$26.52B	$27.07B	$28.27B	$28.07B	$26.08B
Gross Margin	18.0%	19.5%	21.3%	21.2%	21.4%
Operating Income	$-14,076,000,000	$-6,882,000,000	$1.39B	$2.34B	$982.00M
Net Income	$-8,636,000,000	$-3,080,000,000	$4.34B	$2.54B	$456.00M
Net Margin	-5.8%	-2.2%	3.3%	1.9%	0.4%
EPS	$-10.01	$-3.57	$5.02	$2.31	$0.52

Company Overview

Walgreens Boots Alliance, Inc. operates as a pharmacy-led health and beauty retail company. It operates through two segments, the United States and International. The United States segment sells prescription drugs and an assortment of retail products, including health, wellness, beauty, personal care, consumable, and general merchandise products through its retail drugstores. It also provides central specialty pharmacy services and mail services. As of August 31, 2021, this segment operated 8,965 retail stores under the Walgreens and Duane Reade brands in the United States; and five specialty pharmacies. The International segment sells prescription drugs; and health and wellness, beauty, personal care, and other consumer products through its pharmacy-led health and beauty retail stores and optical practices, as well as through boots.com and an integrated mobile application. It also engages in pharmaceutical wholesaling and distribution business in Germany. As of August 31, 2021, this segment operated 4,031 retail stores under the Boots, Benavides, and Ahumada in the United Kingdom, Thailand, Norway, the Republic of Ireland, the Netherlands, Mexico, and Chile; and 548 optical practices, including 160 on a franchise basis. Walgreens Boots Alliance, Inc. was founded in 1901 and is based in Deerfield, Illinois.

Visit Website

Earnings History & Surprises

WBA

Beat Rate

89%

Last 19 quarters

Avg Surprise

+14.6%

EPS vs Estimate

Beats / Misses

17/2

Last 12 quarters

Latest EPS

$0.39

Q4 2025

EPS Surprise History

Q1 24

+4.8%

$0.66vs$0.63

Q1 24

+46.5%

$1.20vs$0.82

Q2 24

-7.5%

$0.63vs$0.68

Q4 24

+8.8%

$0.39vs$0.36

Q1 25

+37.8%

$0.51vs$0.37

Q2 25

+17.8%

$0.63vs$0.54

Q2 25

+16.1%

$0.38vs$0.33

Q4 25

+44.4%

$0.39vs$0.27

Beat Estimate

Missed Estimate

Quarterly EPS Details

Period	Report Date	Estimated EPS	Actual EPS	Surprise	Result
Q4 2025	Oct 21, 2025	$0.27	$0.39	+44.4%	✓ BEAT
Q2 2025	Jun 26, 2025	$0.33	$0.38	+16.1%	✓ BEAT
Q2 2025	Apr 8, 2025	$0.54	$0.63	+17.8%	✓ BEAT
Q1 2025	Jan 10, 2025	$0.37	$0.51	+37.8%	✓ BEAT
Q4 2024	Oct 15, 2024	$0.36	$0.39	+8.8%	✓ BEAT
Q2 2024	Jun 27, 2024	$0.68	$0.63	-7.5%	✗ MISS
Q1 2024	Mar 28, 2024	$0.82	$1.20	+46.5%	✓ BEAT
Q1 2024	Jan 4, 2024	$0.63	$0.66	+4.8%	✓ BEAT
Q4 2023	Nov 22, 2023	—	$-0.21	—	—
Q2 2023	Jun 27, 2023	$1.06	$1.00	-5.7%	✗ MISS
Q1 2023	Mar 28, 2023	$1.10	$1.16	+5.5%	✓ BEAT
Q1 2023	Jan 5, 2023	$1.15	$1.16	+0.9%	✓ BEAT
Q4 2022	Oct 13, 2022	$0.78	$0.80	+2.6%	✓ BEAT
Q2 2022	Jun 30, 2022	$0.95	$0.96	+1.1%	✓ BEAT
Q1 2022	Mar 31, 2022	$1.39	$1.59	+14.4%	✓ BEAT
Q1 2022	Jan 6, 2022	$1.35	$1.68	+24.4%	✓ BEAT
Q4 2021	Oct 14, 2021	$1.03	$1.17	+13.6%	✓ BEAT
Q3 2021	Jul 1, 2021	$1.17	$1.38	+17.9%	✓ BEAT
Q1 2021	Mar 31, 2021	$1.11	$1.26	+13.5%	✓ BEAT
Q1 2021	Jan 7, 2021	$1.02	$1.22	+19.6%	✓ BEAT

Frequently Asked Questions about WBA

What is WBA's current stock price?

Walgreens Boots Alliance, Inc. (WBA) is currently trading at $11.98 per share. The stock has moved +0.50% today.

What is the analyst price target for WBA?

The average analyst price target for WBA is $9.00, based on 1 analyst.

What sector is Walgreens Boots Alliance, Inc. in?

Walgreens Boots Alliance, Inc. operates in the Healthcare sector, specifically within the Medical - Pharmaceuticals industry. The company is traded on the NASDAQ exchange.

What is WBA's market cap?

Walgreens Boots Alliance, Inc. has a market capitalization of $10.37 billion, making it a large-cap company.

Does WBA pay dividends?

No, Walgreens Boots Alliance, Inc. does not currently pay a dividend to shareholders.